Titan Bio Tech Ltd Stock Price Today (NSE: TITANBIO)
Fundamental Score
Titan Bio Tech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Titan Bio Tech Ltd share price today is ₹411.40, down 2.26% on NSE/BSE as of 4 August 2026. Titan Bio Tech Ltd (TITANBIO) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹1.68K (Cr). The 52-week high for TITANBIO share price is ₹1460.00 and the 52-week low is ₹202.05. At a P/E ratio of 56.28x, TITANBIO is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 17.85% and a debt-to-equity ratio of 0.03.
Titan Bio Tech Ltd Share Price Chart — NSE/BSE Historical Performance
Titan Bio Tech Ltd share price chart: 12.51% return over the past month. 52-week high ₹1460.00, 52-week low ₹202.05.
Titan Bio Tech Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹422.00 | ₹429.75 | ₹410.00 | ₹416.60 | 14.67K (Cr) | |
| ₹423.00 | ₹423.00 | ₹412.00 | ₹418.20 | 10.72K (Cr) | |
| ₹426.80 | ₹427.80 | ₹416.00 | ₹419.15 | 8.27K (Cr) | |
| ₹414.90 | ₹432.00 | ₹410.25 | ₹427.80 | 30.80K (Cr) | |
| ₹424.00 | ₹430.00 | ₹411.10 | ₹414.90 | 14.40K (Cr) | |
| ₹425.20 | ₹430.00 | ₹403.95 | ₹428.70 | 39.86K (Cr) | |
| ₹432.20 | ₹432.20 | ₹405.00 | ₹425.20 | 25.05K (Cr) | |
| ₹425.00 | ₹429.95 | ₹405.00 | ₹424.85 | 19.40K (Cr) | |
| ₹396.10 | ₹422.00 | ₹396.10 | ₹418.70 | 25.05K (Cr) | |
| ₹386.00 | ₹408.45 | ₹385.00 | ₹407.15 | 53.25K (Cr) |
Titan Bio Tech Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹422.00 | ₹429.75 | ₹410.00 | ₹416.60 | -1.28% | |
| ₹394.90 | ₹432.20 | ₹355.00 | ₹418.20 | +5.90% | |
| ₹454.00 | ₹469.00 | ₹386.20 | ₹390.40 | -14.01% | |
| ₹495.00 | ₹514.00 | ₹406.00 | ₹441.25 | -10.86% | |
| ₹461.00 | ₹555.65 | ₹392.30 | ₹496.00 | +7.59% | |
| ₹202.05 | ₹457.90 | ₹202.05 | ₹457.70 | +126.53% | |
| ₹998.80 | ₹1460.00 | ₹238.30 | ₹241.80 | -75.79% | |
| ₹1069.00 | ₹1132.35 | ₹910.00 | ₹931.25 | -12.89% | |
| ₹1028.40 | ₹1259.30 | ₹857.00 | ₹1053.80 | +2.47% | |
| ₹1033.15 | ₹1074.00 | ₹885.90 | ₹979.50 | -5.19% | |
| ₹962.00 | ₹1419.00 | ₹916.80 | ₹1054.20 | +9.58% | |
| ₹763.35 | ₹1017.00 | ₹650.59 | ₹948.30 | +24.23% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Overvalued micro-cap specialty chemical company with high momentum but significant downside risk if growth falters.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Titan Biotech hit a 52-week high of on April 7, 2026. The company's stock has shown strong momentum, trading above all key moving averages. In the latest quarter ending December 2025, Titan Biotech reported its highest quarterly net sales of s and a PBT (excluding other income) peak of s. PBDIT also reached a record s.
CORE STORY (THE REAL GAME)
Titan Bio Tech is being priced as a high-growth specialty chemicals play, leveraging both domestic demand and export opportunities. The market narrative is focused on its ability to sustain high growth rates and maintain operational efficiency.
- Strong quarterly results with record net sales of ₹56.51 crores
- Stock price at 52-week high of ₹555.65
- Bullish technical indicators (MACD, Bollinger Bands, KST)
- New order wins or contract announcements
- Better-than-expected earnings in upcoming quarters
- Expansion into new markets or product lines
- Micro-cap status introduces liquidity risk
- High P/E ratio of 35.58x compared to industry P/E of 29.2x
- Potential for rising costs in the specialty chemicals sector
Promoter holding decreased slightly by 0.1%
Indian chemical production is projected to increase by 10.9% in 2026, driven by robust domestic demand and government support.
Profit converting to cash - Free Cash Flow 5Y: ₹54.58 Cr
Expect continued growth in the specialty chemicals sector, but Titan Biotech's high valuation leaves little room for error. Monitor earnings closely and be prepared for volatility.
Primary Thesis Risk
Overvaluation and liquidity risk make this a dangerous game at these levels.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Titan Bio Tech Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Titan Bio Tech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TITANBIO across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (17.85%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.76%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (20.03%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (66.17%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (38.84%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (42.95x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹61.49 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (55.78%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 56.28x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-0.46% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-0.45% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Limited Institutional Interest (FII+DII: 0.03%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Titan Bio Tech Ltd vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Titan Bio Tech Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Titan Bio Tech LtdTitan Bio Tech ...Selected✓ TITANBIO • 524717 | 58.3/100 | ₹411.40₹411 | ₹1682.28₹1682.28 | 56.28Average 56.3 Average | 17.85%Good 17.85% Good | 22.76%Excellent 22.76% Excellent | 0.03Excellent 0.0 Excellent | -0.45%Poor -0.45% Poor | 7.71%Good 7.71% Good | 0.10% |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1611.40₹1611 | ₹159989.82₹159989.82 | 64.97Average 65.0 Average | 23.92%Excellent 23.92% Excellent | 31.02%Excellent 31.02% Excellent | 0.04Excellent 0.0 Excellent | 16.69%Excellent 16.69% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4366.80₹4367 | ₹45440.05₹45440.05 | 77.27Average 77.3 Average | 7.78%Poor 7.78% Poor | 9.86%Poor 9.86% Poor | 0.29Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹7567.50₹7568 | ₹39027.62₹39027.62 | 58.37Average 58.4 Average | 20.26%Excellent 20.26% Excellent | 21.37%Excellent 21.37% Excellent | 0.32Excellent 0.3 Excellent | 22.16%Excellent 22.16% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1662.20₹1662 | ₹23159.08₹23159.08 | 41.37Average 41.4 Average | 9.97%Poor 9.97% Poor | 11.49%Average 11.49% Average | 0.28Excellent 0.3 Excellent | -6.33%Poor -6.33% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LtdAether Industri... AETHER • 543534 | 36.3/100 | ₹1539.60₹1540 | ₹19624.13₹19624.13 | 86.74Average 86.7 Average | 9.66%Poor 9.66% Poor | 11.92%Average 11.92% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.00% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹489.10₹489 | ₹18171.13₹18171.13 | 44.10Average 44.1 Average | 7.13%Poor 7.13% Poor | 6.85%Poor 6.85% Poor | 0.83Good 0.8 Good | -4.67%Poor -4.67% Poor | 12.96%Good 12.96% Good | 0.20% |
Atul LtdAtul Ltd... ATUL • 500027 | 58.2/100 | ₹6736.50₹6737 | ₹18051.49₹18051.49 | 26.58Average 26.6 Average | 11.49%Average 11.49% Average | 14.90%Average 14.90% Average | 0.03Excellent 0.0 Excellent | 1.26%Average 1.26% Average | 10.95%Good 10.95% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52.2/100 | ₹3633.80₹3634 | ₹16002.35₹16002.35 | 38.38Average 38.4 Average | 10.92%Average 10.92% Average | 14.68%Average 14.68% Average | 0.03Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.41%Good 9.41% Good | 0.68% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹4816.50₹4817 | ₹15713.17₹15713.17 | 38.15Average 38.1 Average | 16.61%Good 16.61% Good | 21.47%Excellent 21.47% Excellent | 0.03Excellent 0.0 Excellent | 27.91%Excellent 27.91% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1207.80₹1208 | ₹14449.70₹14449.70 | 84.94Average 84.9 Average | 5.50%Poor 5.50% Poor | 7.36%Poor 7.36% Poor | 0.56Good 0.6 Good | 19.29%Excellent 19.29% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price159989.82 Cr
- Gujarat Fluorochemicals Ltd share price45440.05 Cr
- Navin Fluorine International Ltd share price39027.62 Cr
- Deepak Nitrite Ltd share price23159.08 Cr
- Aether Industries Ltd share price19624.13 Cr
Titan Bio Tech Ltd PE Ratio History
Historical price-to-earnings ratio for TITANBIO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹30.07 | ₹732.75 | 24.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Titan Bio Tech Ltd Dividend History
Annual cash dividends paid by TITANBIO — dividend yield 0.10%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹1.65 Cr |
| FY 2024 | ₹1.49 Cr |
| FY 2023 | ₹1.24 Cr |
| FY 2022 | ₹1.24 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Titan Bio Tech Ltd Quarterly Performance
Latest quarterly metrics for TITANBIO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
38.84%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
66.17%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
7.71%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-0.45%
Compounded annual net profit growth over 5 years
Titan Bio Tech Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TITANBIO — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Titan Bio Tech Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Titan Bio Tech Ltd (TITANBIO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Titan Bio Tech Ltd
About TITANBIO (Titan Bio Tech Ltd)
Titan Bio Tech Ltd is a pioneering force in the specialty chemicals sector, dedicated to the research, development, and production of innovative biological solutions. Focusing on c...utting-edge bio-processing techniques, TITANBIO creates high-performance chemical components for a wide array of industrial applications. The company emphasizes sustainable practices throughout its manufacturing processes, striving to minimize environmental impact while maximizing product efficacy. Through strategic partnerships and a commitment to technological advancement, TITANBIO seeks to remain at the forefront of the industry, anticipating and meeting the evolving needs of its diverse clientele. The company places a strong emphasis on quality control, ensuring that every product meets rigorous standards for purity, potency, and safety. TITANBIO distinguishes itself by offering a comprehensive portfolio of specialty chemicals tailored to enhance product performance and sustainability. Their extensive range of offerings includes advanced protein derivatives, fermentation-derived ingredients, and other bio-active compounds. These specialized chemicals find application in various sectors, including food and beverage, cosmetics, pharmaceuticals, and animal nutrition. TITANBIO prides itself on its ability to customize solutions to meet specific customer requirements, leveraging its expertise in bio-chemistry and chemical engineering. The company's R&D team is constantly exploring new avenues for innovation, developing novel solutions that address emerging market trends and environmental challenges. The product's applications range from enriching animal feed formulations, creating advanced bio-fertilizers, or enabling sustainable cosmetic development. TITANBIO is committed to global outreach, with a growing presence in both established and emerging markets. The company prioritizes building strong, long-term relationships with its customers, providing technical support and expert guidance to ensure optimal product utilization. Through active participation in industry events and research collaborations, TITANBIO aims to foster knowledge sharing and drive innovation within the specialty chemicals community. Their commitment to excellence extends beyond product quality to encompass customer service, environmental responsibility, and ethical business practices. TITANBIO aspires to be a trusted partner for businesses seeking sustainable and high-performance chemical solutions, contributing to a more environmentally friendly and technologically advanced future. The company's emphasis on regulatory compliance and safety ensures that its products meet the highest global standards.
Company Details
Key Leadership
Corporate Events
TITANBIO Share Price: Frequently Asked Questions
What is the current share price of Titan Bio Tech Ltd?
Titan Bio Tech Ltd (TITANBIO) trades at ₹411.40 on NSE and BSE. Market cap ₹1.68K (Cr). Educational data only.
What is the P/E ratio of Titan Bio Tech Ltd?
Titan Bio Tech Ltd has a P/E of 56.28x vs industry average 31.95x.
What is the Bull Run score for Titan Bio Tech Ltd?
Titan Bio Tech Ltd has a Bull Run score of 58.3/100 based on 25+ financial parameters.
Does Titan Bio Tech Ltd pay dividends?
Titan Bio Tech Ltd has a dividend yield of 0.10%. Past dividends don't guarantee future payments.
What is the ROE of Titan Bio Tech Ltd?
Titan Bio Tech Ltd has ROE of 17.85%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Titan Bio Tech Ltd?
Titan Bio Tech Ltd has debt-to-equity of 0.03.
Is Titan Bio Tech Ltd a good investment?
Bull Run gives Titan Bio Tech Ltd a score of 58.3/100. This is not investment advice — consult a SEBI-registered advisor.